InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
1.810
-0.120 (-6.22%)
At close: Jan 6, 2026, 4:00 PM EST
1.820
+0.010 (0.55%)
After-hours: Jan 6, 2026, 6:38 PM EST
InspireMD Revenue
InspireMD had revenue of $2.52M in the quarter ending September 30, 2025, with 39.39% growth. This brings the company's revenue in the last twelve months to $7.78M, up 14.04% year-over-year. In the year 2024, InspireMD had annual revenue of $7.01M with 12.96% growth.
Revenue (ttm)
$7.78M
Revenue Growth
+14.04%
P/S Ratio
13.91
Revenue / Employee
$90,453
Employees
86
Market Cap
76.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | 3.72M | 120.00K | 3.33% |
| Dec 31, 2018 | 3.60M | 840.00K | 30.42% |
| Dec 31, 2017 | 2.76M | 867.00K | 45.78% |
| Dec 31, 2016 | 1.89M | -416.00K | -18.01% |
| Dec 31, 2015 | 2.31M | -508.00K | -18.03% |
| Dec 31, 2014 | 2.82M | -3.30M | -53.95% |
| Dec 31, 2013 | 6.12M | 115.00K | 1.92% |
| Dec 31, 2011 | 6.00M | 1.06M | 21.32% |
| Dec 31, 2010 | 4.95M | 1.54M | 45.09% |
| Dec 31, 2009 | 3.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NSPR News
- 6 weeks ago - Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - GlobeNewsWire
- 6 weeks ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - InspireMD Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD Names Peter A. Soukas, M.D. - GlobeNewsWire
- 2 months ago - InspireMD to Announce Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - InspireMD Announces the Appointment of Dan Dearen to its Board of Directors - GlobeNewsWire